精能醫學股份有限公司 Approved
最後更新時間 2025/07/10 , 06:04 PM
最後更新時間 2025/07/10 , 06:04 PM
負責人
Lin,Jin-Biao
統一編號
54156063
成立日期
2013/01/10
資本額
NT$500,000,000
實收資本額
NT$239,654,510
股票代號
6852
電話
#803
地址
9-5F, No. 97, Sec. 1, Sintai 5th Rd., Xizhi Dist., New Taipei City, 221, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Lin,Jin-Biao Chairman 19.84%
Lin,Wei-Zuo Director 3.03%
Wen,Yong-Rui Director 0.48%
Huang,Xiu-Mei Independent Director 0.00%
Su,Min-Xiong Independent Director 0.00%
Yang,Shi-Cong Independent Director 0.00%
營業項目
  • Wholesale of Computers, Computer Peripheral Equipment and Software(464111)
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • Wholesale of Electronic and Communication Equipment and Parts(464211)
  • Retail Sale of Computers, Computer Peripheral Equipment and Software in Specialized Stores(483112)
  • 公司歷程
  • Change Person in Charge to Lin,Jin-Biao
    2016/05/24
  • Change Capital to 500,000,000
    2016/05/12
  • Change Capital to 80,000,000
    2014/09/30
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 18,730 31,415 31,719
    Operating cost 3,683 7,091 4,646
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 15,047 24,324 27,073
    Unrealized profit (loss) on sales of goods 162 645 -
    Realized profit (loss) on sales of goods 91 - -
    Operating gross profit (loss), net 14,976 23,679 27,073
    Operating expenses 45,894 127,355 114,850
    Other gain (loss), net - - -
    Operating profit (loss) -30,918 -103,676 -87,777
    Non-operating income and expenses -2,992 -7,078 -1,437
    Net profit (loss) before tax -33,910 -110,754 -89,214
    Income tax expense (benefits) 0 0 0
    Net profit (loss) of ongoing business for the current period -33,910 -110,754 -89,214
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -33,910 -110,754 -89,214
    Other comprehensive profit (loss), net 0 0 0
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -33,910 -110,754 -89,214
    Net profit (loss) attributable to owners of parent company -33,910 -110,754 -89,214
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company -33,910 -110,754 -89,214
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) -1 -4 -3
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities -16,873 -121,570 -74,311
    Net cash inflows (outflows) from investing activities 121 -4,434 -17,799
    Net cash inflow (outflow) from financing activities 2,987 53,897 -4,341
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period -13,765 -72,107 -96,451
    Beginning balance of cash and cash equivalents 16,368 88,475 184,926
    Ending balance of cash and cash equivalents 2,603 16,368 88,475
    項目 2024 2023 2022
    Current asset 32,330 56,409 103,383
    Non-current asset 44,203 58,629 72,180
    Total asset 76,533 115,038 175,563
    Current liability 30,012 48,566 34,891
    Non-current liability 53,945 39,986 55,932
    Total liability 83,957 88,552 90,823
    share capital 239,655 239,655 234,655
    Equity - secruity token - - -
    capital reserve 154,800 154,800 107,300
    retained earning -401,879 -367,969 -257,215
    Other equity 0 0 0
    Treasury stock - - -
    Total equity attributable to owners of parent company -7,424 26,486 84,740
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity -7,424 26,486 84,740
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 0 1 3
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • EGO
  • Neuro Block設計字
  • 精能
  • 施痛停
  • +RF
  • neuro Block Ver 2.0B
  • GIMER Medical
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。